Cleared Traditional

K881771 - SENSOCOR(TM) DIASYS

K881771 is the FDA 510(k) clearance for SENSOCOR(TM) DIASYS by Sensormedix, Inc.. It is a Class 2 Cardiovascular device (product code DXN) cleared through the Traditional 510(k) pathway after a 261-day FDA review.

K881771 · Sensormedix, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1989
Decision
261d
Days
Class 2
Risk

K881771 is an FDA 510(k) clearance for the SENSOCOR(TM) DIASYS. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Sensormedix, Inc. (Fort Lauderdale, US). The FDA issued a Cleared decision on January 12, 1989 after a review of 261 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Sensormedix, Inc. devices

Submission Details

510(k) Number K881771 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 26, 1988
Decision Date January 12, 1989
Days to Decision 261 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
136d slower than avg
Panel avg: 125d · This submission: 261d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 527
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K881771.
TYPE 9225 NIBP
K890005 · S & W Medico Teknik · May 1989
TAKEDA MEDICAL AUTO. DIGITAL BLOOD PRES. MONITOR
K882824 · A&D Engineering, Inc. · Jan 1989
TAKEDA MEDICAL AUTO. DIG. BLOOD PRES. METER W/PRIN
K882825 · A&D Engineering, Inc. · Jan 1989
CARDIOCAP(TM) CM-104 MONITOR
K884955 · Datex Division Instrumentarium Corp. · Dec 1988
POCKET MANOMETER
K880599 · Abbott Laboratories · Oct 1988
MODEL BPS08 BLOOD PRESSURE MODULE
K881155 · Fresenius USA, Inc. · Jul 1988